"pancreatic tumor progression" trang 13 - tải miễn phí từ tailieunhanh
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer

CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer
8    77    0
Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis

Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
8    89    0
A prospective clinical and biological database for pancreatic adenocarcinoma: The BACAP cohort

A prospective clinical and biological database for pancreatic adenocarcinoma: The BACAP cohort
8    45    0
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
6    82    0
Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
10    91    0
Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells

Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells
15    87    0
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study
7    80    0
Preoperative maximum standardized uptake value and carbohydrate antigen 19– 9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma

Preoperative maximum standardized uptake value and carbohydrate antigen 19– 9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma
5    82    0
IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
11    86    0
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial

Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial
9    66    0
The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: A multicenter cohort study

The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: A multicenter cohort study
11    47    0
Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: A propensity score analysis

Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: A propensity score analysis
11    82    0
Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment

Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment
8    73    1
An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker

An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
11    51    1
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer

Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer
12    64    1
MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma

MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma
14    62    1
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes

Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
13    55    1
Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps

Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps
12    68    1
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
10    33    1
Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study

Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study
11    39    1